¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"contact compound scanner"¿¡ ´ëÇÑ ´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • scanner
    ÁÖ»ç±â(ñËÞÛÐï)
  • contact activation cofactor
    "Á¢ÃËȰ¼º º¸ÀÎÀÚ(ïÈõºüÀàõÜÍì×í­), (ÔÒ) high molecular weight kininogen"
  • contact factor
    "Á¢ÃËÀÎÀÚ(ïÈõºì×í­), (ÔÒ) Hageman factor"
  • contact guidance
    Á¢Ã˾ȳ»(ïÈõºäÐÒ®)
  • contact hypersensitivity
    Á¢Ã˰ú¹ÎÁõ(ïÈõºÎ¦ÚÂñø)
  • contact inhibition
    Á¢ÃËÀúÇØ(ïÈõºîÁúª)
  • contact map
    Á¢ÃËÁöµµ(ïÈõºò¢Óñ)
  • contact surface
    Á¢Ã˸é(ïÈõºØü)
  • alicyclic compound
    ºñ(Þª)°í¸®Çü(û¡)È­ÇÕ¹°(ûùùêÚª)
  • anticancer compound
    Ç×¾ÏÈ­ÇÕ¹°(ù÷äßûùùêÚª)
  • antithyroid compound
    Ç×°©»ó¼± È­ÇÕ¹°(ù÷Ë£ßÒàÍûùùêÚª)
  • azo compound
    ¾ÆÁ¶È­ÇÕ¹°(ûùùêÚª)
  • carbamino compound
    Ä«¸£¹Ù¸¶À̵å È­ÇÕ¹°(ûùùêÚª)
  • compound
    È­ÇÕ¹°(ûùùêÚª)
  • compound lipid
    "È­ÇÕÁöÁú(ûùùêò·òõ), (ÔÒ) complex lipid"
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á